All News

generic

All News

Creo Pharma are Cyber Essentials accredited

10/04/19
Creo Pharma are Cyber Essentials accredited
Launched by the UK Government in 2014, the Cyber Essentials Scheme looks to improve organisations technical controls against online threats. As of 12th February 2019, Creo Pharma were confirmed as Cyber Essentials accredited, meaning that our IT systems are suitably secure against common online threats. This certification ensures Creo Pharma continue to take online security seriously, for...
Read

Zentiva announces the acquisition of Creo Pharmaceuticals Ltd. in the UK

03/04/19
Zentiva announces the acquisition of Creo Pharmaceuticals Ltd. in the UK
PRAGUE – April 1st, 2019: Zentiva Group a.s. is announcing the acquisition of Creo Pharmaceuticals Ltd. in the UK, a subsidiary of Amneal Pharmaceuticals, Inc. (NYSE: AMRX).Nick Haggar, CEO of Zentiva stated: “Zentiva is delighted to confirm the acquisition of Creo Pharma which will strengthen Zentiva’s position in the UK. This move reflects our confidence in the UK and...
Read

Creo Pharma - GDPR statement

27/06/18
Creo Pharma - GDPR statement
The new General Data Protection Regulation (GDPR) became effective from 25th May 2018. We at Creo Pharma will continue to respect the security and sensitivity of information shared with us. We have updated our Privacy policy to reflect the changes in Regulation, and to provide further information on how we collect, store and use your personal data.You can read our full updated policy on our Terms...
Read

Creo Pharma Transfers of Value (ToV) for 2017 to Healthcare Professionals

26/06/18
Creo Pharma Transfers of Value (ToV) for 2017 to Healthcare Professionals
As a member of the BGMA, Creo Pharma are signed up to the Medicines for Europe Code of Conduct. The information below is Creo Pharma’s 'Transfers of Value' disclosure for 2017.The code is inclusive of all Healthcare Professionals who received a transfer of value from Creo Pharma. This disclosure ensures Creo Pharma’s continued compliance with the Medicines for Europe Code of...
Read

Trazodone 100mg/5ml oral solution sugar-free (120ml)

26/01/18
Trazodone 100mg/5ml oral solution sugar-free (120ml)
We are delighted to announce that in February, Creo Pharma was the first supplier able to offer a licensed Trazodone 100mg/5ml oral solution sugar-free (120ml). For more information, please view the Creo Pharma Database Listing for this product.
Read

Ranitidine 150mg/5ml oral solution sugar-free (150ml)

18/01/18
Ranitidine 150mg/5ml oral solution sugar-free (150ml)
We are delighted to announce that in November, Creo Pharma was the first supplier able to offer a licensed Ranitidine 150mg/5ml oral solution sugar-free (150ml). For more information, please view the Creo Pharma Database Listing for this product.
Read

Alendronic Acid and Colecalciferol tablets

30/08/17
Alendronic Acid and Colecalciferol tablets
On 30th August 2017, Creo Pharma dispatched launch orders for its generic Alendronic acid 70 mg and Colecalciferol 2800IU tablets to customers. For more information, please view the Creo Pharma Database Listing for this product.
Read